아르테미신산시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 부문별 : 유형별(전합성, 반합성), 용도별(항말라리아 주사제, 항말라리아 정제), 지역별 세분화 및 경쟁 구도(2020-2030년)

The Global Artemisinic Acid Market, valued at USD 521.9 Million in 2024, is projected to experience a CAGR of 4.11% to reach USD 664.57 Million by 2030. Artemisinic acid, a pivotal sesquiterpene derived primarily from *Artemisia annua L. *, functions as a critical precursor for the semi-synthesis of artemisinin, an active pharmaceutical ingredient essential in antimalarial drugs. The market's expansion is robustly supported by several key drivers, including the persistent global burden of malaria, which sustains the demand for artemisinin-based combination therapies, and continuous advancements in biotechnological production methods like microbial fermentation, offering enhanced supply chain reliability and cost predictability. Furthermore, increasing investments in research and development exploring diverse therapeutic applications beyond malaria also contribute to market growth.

Key Market Drivers

The global artemisinic acid market is significantly influenced by the persistent burden of malaria worldwide and continuous advancements in biotechnological production methods. The enduring health crisis of malaria consistently drives demand for artemisinin-based combination therapies, which in turn elevates the need for artemisinic acid as a crucial precursor. The crisis necessitates a steady supply of effective antimalarial drugs. According to the World Health Organization (WHO), in December 2024, the Malaria Report stated that global malaria cases reached an estimated 263 million in 2023, underscoring the vast and ongoing need for treatment. Simultaneously, advancements in biotechnological production methods significantly enhance supply chain reliability and cost predictability for artemisinic acid. Synthetic biology innovations, particularly engineered microbial fermentation, revolutionize manufacturing.

Key Market Challenges

The emergence of artemisinin resistance in malaria parasites poses a significant challenge to the Global Artemisinic Acid Market. This resistance directly undermines the efficacy of artemisinin-based combination therapies, which are currently pivotal for malaria treatment. As parasites develop resistance, the sustained effectiveness of these essential drugs is jeopardized, leading to reduced confidence in artemisinin as a reliable active pharmaceutical ingredient. This instability threatens the consistent demand for artemisinic acid, its key precursor.

Developing new antimalarial drugs to overcome this resistance represents a substantial financial burden on the pharmaceutical industry. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the estimated cost for researching and developing a new chemical or biological entity was €3,130 million (equivalent to $3,296 million in 2022 dollars) in 2022. This considerable investment, required for ongoing innovation to counteract resistance, diverts resources and increases development timelines, thereby impeding stable market growth for established precursors like artemisinic acid.

Key Market Trends

The prioritization of sustainable production processes is emerging as a critical trend within the global artemisinic acid market. This focus extends beyond mere compliance, reflecting a concerted effort across the pharmaceutical industry to minimize environmental impact and promote ethical manufacturing practices throughout the supply chain. Companies are increasingly investing in green chemistry principles, adopting renewable energy sources, and implementing waste reduction strategies to enhance their ecological footprint. According to Cytiva's 2024 Global Biopharma Sustainability Review, sustainability ranks as the number one priority for 62% of biopharma companies over the next five years, indicating a significant shift towards environmentally conscious operations. This commitment drives innovation in manufacturing techniques, promoting resource efficiency and a reduced reliance on hazardous materials in the production of key pharmaceutical precursors like artemisinic acid.

Key Market Players

• Sanofi SA
• KPC Pharmaceuticals, Inc
• Guilin Pharmaceutical Co., Ltd
• Calyx Chemicals and Pharmaceuticals Ltd.
• Novartis AG
• Ipca Laboratories Ltd.
• Cipla Inc.
• Shin Poong Pharm Co., Ltd.
• Rupus Global Limited
• AdvacarePharma

Report Scope:

In this report, the Global Artemisinic Acid Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Artemisinic Acid Market, By Type:

• Total Synthesis
• Semi synthesis

Artemisinic Acid Market, By Applications:

• Antimalarial Injections
• Antimalarial Tablets

Artemisinic Acid Market, By Region:

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• North America
  • United States
  • Canada
  • Mexico

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Artemisinic Acid Market.

Available Customizations:

Global Artemisinic Acid Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Artemisinic Acid Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Total Synthesis, Semi synthesis)
  • 5.2.2. By Applications (Antimalarial Injections, Antimalarial Tablets)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Artemisinic Acid Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Applications
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Artemisinic Acid Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Applications
  • 6.3.2. Canada Artemisinic Acid Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Applications
  • 6.3.3. Mexico Artemisinic Acid Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Applications

7. Europe Artemisinic Acid Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Applications
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Artemisinic Acid Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Applications
  • 7.3.2. France Artemisinic Acid Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Applications
  • 7.3.3. United Kingdom Artemisinic Acid Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Applications
  • 7.3.4. Italy Artemisinic Acid Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Applications
  • 7.3.5. Spain Artemisinic Acid Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Applications

8. Asia Pacific Artemisinic Acid Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Applications
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Artemisinic Acid Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Applications
  • 8.3.2. India Artemisinic Acid Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Applications
  • 8.3.3. Japan Artemisinic Acid Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Applications
  • 8.3.4. South Korea Artemisinic Acid Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Applications
  • 8.3.5. Australia Artemisinic Acid Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Applications

9. Middle East & Africa Artemisinic Acid Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Applications
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Artemisinic Acid Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Applications
  • 9.3.2. UAE Artemisinic Acid Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Applications
  • 9.3.3. South Africa Artemisinic Acid Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Applications

10. South America Artemisinic Acid Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Applications
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Artemisinic Acid Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Applications
  • 10.3.2. Colombia Artemisinic Acid Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Applications
  • 10.3.3. Argentina Artemisinic Acid Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Applications

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Artemisinic Acid Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Sanofi SA
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. KPC Pharmaceuticals, Inc
• 15.3. Guilin Pharmaceutical Co., Ltd
• 15.4. Calyx Chemicals and Pharmaceuticals Ltd.
• 15.5. Novartis AG
• 15.6. Ipca Laboratories Ltd.
• 15.7. Cipla Inc.
• 15.8. Shin Poong Pharm Co., Ltd.
• 15.9. Rupus Global Limited
• 15.10. AdvacarePharma

16. Strategic Recommendations

17. About Us & Disclaimer